177 related articles for article (PubMed ID: 28152251)
1. Diffusion-weighted MRI treatment monitoring of primary hypofractionated proton and carbon ion prostate cancer irradiation using raster scan technique.
Wolf MB; Edler C; Tichy D; Röthke MC; Schlemmer HP; Herfarth K; Bonekamp D
J Magn Reson Imaging; 2017 Sep; 46(3):850-860. PubMed ID: 28152251
[TBL] [Abstract][Full Text] [Related]
2. Dynamic contrast enhanced MRI monitoring of primary proton and carbon ion irradiation of prostate cancer using a novel hypofractionated raster scan technique.
Bonekamp D; Wolf MB; Edler C; Katayama S; Schlemmer HP; Herfarth K; Röthke M
Radiother Oncol; 2016 Aug; 120(2):313-9. PubMed ID: 27237059
[TBL] [Abstract][Full Text] [Related]
3. The predictive role of ADC values in prostate cancer patients treated with carbon-ion radiotherapy: initial clinical experience at Shanghai Proton and Heavy Ion Center (SPHIC).
Qi WX; Zhang Q; Li P; Zhang XM; Zhang GY; Wu B; Lu JJ; Jiang GL; Fu S
J Cancer Res Clin Oncol; 2016 Jun; 142(6):1361-7. PubMed ID: 27008005
[TBL] [Abstract][Full Text] [Related]
4. DWI of the prostate: Comparison of a faster diagonal acquisition to standard three-scan trace acquisition.
Corcuera-Solano I; Wagner M; Hectors S; Lewis S; Titelbaum N; Stemmer A; Rastinehad A; Tewari A; Taouli B
J Magn Reson Imaging; 2017 Dec; 46(6):1767-1775. PubMed ID: 28301097
[TBL] [Abstract][Full Text] [Related]
5. Assessment of response to radiotherapy for prostate cancer: value of diffusion-weighted MRI at 3 T.
Song I; Kim CK; Park BK; Park W
AJR Am J Roentgenol; 2010 Jun; 194(6):W477-82. PubMed ID: 20489065
[TBL] [Abstract][Full Text] [Related]
6. Risk Stratification of Prostate Cancer Using the Combination of Histogram Analysis of Apparent Diffusion Coefficient Across Tumor Diffusion Volume and Clinical Information: A Pilot Study.
Zhang Z; Xu H; Xue Y; Li J; Ye Q
J Magn Reson Imaging; 2019 Feb; 49(2):556-564. PubMed ID: 30173421
[TBL] [Abstract][Full Text] [Related]
7. Diffusion-weighted imaging to evaluate for changes from androgen deprivation therapy in prostate cancer.
Kim AY; Kim CK; Park SY; Park BK
AJR Am J Roentgenol; 2014 Dec; 203(6):W645-50. PubMed ID: 25415730
[TBL] [Abstract][Full Text] [Related]
8. Early changes in apparent diffusion coefficient from diffusion-weighted MR imaging during radiotherapy for prostate cancer.
Park SY; Kim CK; Park BK; Park W; Park HC; Han DH; Kim B
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):749-55. PubMed ID: 22154286
[TBL] [Abstract][Full Text] [Related]
9. Diffusion weighted MRI as an early predictor of tumor response to hypofractionated stereotactic boost for prostate cancer.
Pasquier D; Hadj Henni A; Escande A; Tresch E; Reynaert N; Colot O; Lartigau E; Betrouni N
Sci Rep; 2018 Jul; 8(1):10407. PubMed ID: 29991748
[TBL] [Abstract][Full Text] [Related]
10. Utility of computed diffusion-weighted MRI for predicting aggressiveness of prostate cancer.
Waseda Y; Yoshida S; Takahara T; Kwee TC; Matsuoka Y; Saito K; Kihara K; Fujii Y
J Magn Reson Imaging; 2017 Aug; 46(2):490-496. PubMed ID: 28152258
[TBL] [Abstract][Full Text] [Related]
11. Probing structure of normal and malignant prostate tissue before and after radiation therapy with luminal water fraction and diffusion-weighted MRI.
Carlin D; Orton MR; Collins D; deSouza NM
J Magn Reson Imaging; 2019 Aug; 50(2):619-627. PubMed ID: 30589150
[TBL] [Abstract][Full Text] [Related]
12. Histogram analysis of stretched-exponential and monoexponential diffusion-weighted imaging models for distinguishing low and intermediate/high gleason scores in prostate carcinoma.
Liu W; Liu XH; Tang W; Gao HB; Zhou BN; Zhou LP
J Magn Reson Imaging; 2018 Aug; 48(2):491-498. PubMed ID: 29412492
[TBL] [Abstract][Full Text] [Related]
13. Incremental value of high b value diffusion-weighted magnetic resonance imaging at 3-T for prediction of extracapsular extension in patients with prostate cancer: preliminary experience.
Kido A; Tamada T; Sone T; Kanomata N; Miyaji Y; Yamamoto A; Ito K
Radiol Med; 2017 Mar; 122(3):228-238. PubMed ID: 27943099
[TBL] [Abstract][Full Text] [Related]
14. Monitoring radiotherapy induced tissue changes in localized prostate cancer by multi-parametric magnetic resonance imaging (MP-MRI).
Wu X; Reinikainen P; Kapanen M; Vierikko T; Ryymin P; Kellokumpu-Lehtinen PL
Diagn Interv Imaging; 2019 Nov; 100(11):699-708. PubMed ID: 31257114
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
[TBL] [Abstract][Full Text] [Related]
16. Diffusion radiomics analysis of intratumoral heterogeneity in a murine prostate cancer model following radiotherapy: Pixelwise correlation with histology.
Lin YC; Lin G; Hong JH; Lin YP; Chen FH; Ng SH; Wang CC
J Magn Reson Imaging; 2017 Aug; 46(2):483-489. PubMed ID: 28176411
[TBL] [Abstract][Full Text] [Related]
17. Exploratory study of geometric distortion correction of prostate diffusion-weighted imaging using B
Tong A; Lemberskiy G; Huang C; Shanbhogue K; Feiweier T; Rosenkrantz AB
J Magn Reson Imaging; 2019 Nov; 50(5):1614-1619. PubMed ID: 30990941
[TBL] [Abstract][Full Text] [Related]
18. Prostate Cancer: assessing the effects of androgen-deprivation therapy using quantitative diffusion-weighted and dynamic contrast-enhanced MRI.
Hötker AM; Mazaheri Y; Zheng J; Moskowitz CS; Berkowitz J; Lantos JE; Pei X; Zelefsky MJ; Hricak H; Akin O
Eur Radiol; 2015 Sep; 25(9):2665-72. PubMed ID: 25820537
[TBL] [Abstract][Full Text] [Related]
19. Diffusion-weighted MRI Provides a Useful Biomarker for Evaluation of Radiotherapy Efficacy in Patients with Prostate Cancer.
Wu X; Reinikainen P; Kapanen M; Vierikko T; Ryymin P; Kellokumpu-Lehtinen PL
Anticancer Res; 2017 Sep; 37(9):5027-5032. PubMed ID: 28870929
[TBL] [Abstract][Full Text] [Related]
20. Diffusion-weighted MRI of urinary bladder and prostate cancers.
Kiliçkesmez O; Cimilli T; Inci E; Kayhan A; Bayramoğlu S; Taşdelen N; Gürmen N
Diagn Interv Radiol; 2009 Jun; 15(2):104-10. PubMed ID: 19517380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
